ArticleCureus2023

Comparison of the Efficacy and Safety Profiles of Different P2Y12 Inhibitors in Patients With ST-Segment Elevation Myocardial Infarction in the COVID-19 Era.

Ali N Kaya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.